Back to Article
A Retrospective, Cross-sectional Hospital-based Study to Determine the Epidemiological, Clinical and Comorbidity Characteristics in Older Adults with Psoriasis
Global Journal of Epidemiology and Infectious Disease
| Vol 2, Issue 1
Table 4. Systemic comorbidity profile inElderly and Ultra elderly psoriatic groups.
| Characteristics | Elderly | Ultraelderly | ||||||
| Freq | % | Freq | % | Grand Total | % | P value | ||
| Associated Comorbidity | No | 56 | 39.7 | 7 | 31.8 | 63 | 38.7 | 0.24 |
| Yes | 85 | 60.3 | 15 | 68.2 | 100 | 61.3 | ||
| Arterial Hypertension(HTN) | 67 | 47.5 | 14 | 63.6 | 81 | 49.7 | 0.12 | |
| < 5 years | 13 | 19.4 | 3 | 21.4 | 16 | 19.8 | ||
| 5-10 years | 24 | 35.8 | 2 | 9.09 | 26 | 32.1 | ||
| > 10 years | 30 | 44.8 | 9 | 40.9 | 39 | 48.2 | ||
| Anti HTN Drugs | ||||||||
| Calcium Channel Blockers | 52 | 77.6 | 13 | 92.9 | 65 | 80.3 | ||
| Diuretics | 9 | 13.4 | 1 | 4.6 | 10 | 12.4 | ||
| Angiotensin Converting Enzyme Inhibitors | 15 | 22.4 | 5 | 22.7 | 20 | 24.7 | ||
| Angiotensin Receptor Blockers | 39 | 58.2 | 7 | 31.8 | 46 | 56.8 | ||
| Diabetes Mellitus type II(DM) | 29 | 20.6 | 7 | 31.8 | 36 | 22.1 | ||
| < 5 years | 6 | 20.7 | 0 | 0 | 6 | 16.7 | ||
| 5-10 years | 15 | 51.7 | 0 | 0 | 15 | 9.2 | ||
| > 10 years | 8 | 27.6 | 7 | 31.82 | 15 | 9.2 | ||
| Hypoglycaemic Drugs | ||||||||
| Metformin | 25 | 86.2 | 7 | 31.8 | 32 | 88.9 | ||
| Sulfonylureas | 21 | 72.4 | 7 | 31.8 | 28 | 77.8 | ||
| Thiozolididiones | 7 | 24.1 | 3 | 13.6 | 10 | 27.8 | ||
| Acarbose | 1 | 3.5 | 0 | 0 | 1 | 2.8 | ||
| Meglitides | 6 | 20.7 | 2 | 9.1 | 8 | 22.2 | ||
| Insulin | 1 | 3.5 | 0 | 0 | 1 | 2.8 | ||
| Dyslipidemia | 33 | 23.4 | 9 | 41 | 42 | 25.8 | ||
| < 5 years | 5 | 15.2 | 1 | 1.1 | 6 | 14.3 | ||
| 5-10 years | 16 | 48.5 | 1 | 1.1 | 17 | 40.5 | ||
| > 10 years | 12 | 36.4 | 7 | 77.8 | 19 | 45.2 | ||
| Ischaemic Heart Disease | 11 | 7.8 | 6 | 27.3 | 17 | 10.43 | ||
| < 5 years | 3 | 27.3 | 3 | 50 | 6 | 35.3 | ||
| 5-10 years | 4 | 36.4 | 0 | 0 | 4 | 23.5 | ||
| > 10 years | 4 | 36.4 | 3 | 50 | 7 | 41.2 | ||
| Metabolic syndrome | 22 | 15.6 | 7 | 31.8 | 29 | 17.8 | ||
| Hypothyroidism | 4 | 2.8 | 1 | 4.55 | 5 | 3.1 | ||
| < 5 years | 0 | 0 | 0 | 0 | 0 | |||
| 5-10 years | 3 | 75 | 0 | 0 | 3 | 60 | ||
| > 10 years | 1 | 25 | 1 | 100 | 2 | 40 | ||
| Thyroxine | 3 | 75 | 1 | 4.55 | 4 | 80 | ||
| Benign Prostatic Hyperplasia | 5 | 3.6 | 1 | 4.55 | 6 | 5.2 | ||
| < 5 years | 2 | 40 | 1 | 100 | 3 | 50 | ||
| 5-10 years | 1 | 20 | 0 | 0 | 1 | 16.7 | ||
| > 10 years | 2 | 40 | 0 | 0 | 2 | 33.3 | ||
| Athritis except Psoriatic arthritis | 4 | 2.8 | 0 | 0 | 4 | 2.4 | ||
| < 5 years | 1 | 25 | 0 | 0 | 1 | 25 | ||
| 5-10 years | 1 | 25 | 0 | 0 | 1 | 25 | ||
| > 10 years | 2 | 50 | 0 | 0 | 2 | 50 | ||
| Renal disease | 2 | 1.4 | 0 | 0 | 2 | 1.2 | ||
| < 5 years | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 5-10 years | 1 | 50 | 0 | 0 | 1 | 50 | ||
| > 10 years | 1 | 50 | 0 | 0 | 1 | 50 | ||
| Others | 8 | 5.7 | 2 | 9.1 | 10 | 6.1 | ||
| < 5 years | 3 | 37.5 | 1 | 50 | 4 | 40 | ||
| 5-10 years | 3 | 37.5 | 0 | 0 | 3 | 30 | ||
| > 10 years | 2 | 25 | 1 | 50 | 3 | 30 | ||